Umehara H, Minami Y, Domae N, Bloom E T
Division of Cellular and Gene Therapies (HFM-518), FDA, Bethesda, MD 20892.
Int Immunol. 1994 Jul;6(7):1071-80. doi: 10.1093/intimm/6.7.1071.
Previously we reported that surface expression of lymphocyte function-associated antigen-1 (LFA-1), the primary leukocyte integrin on human natural killer (NK) and lymphokine-activated killer (LAK) cells, does not differ between NK and LAK cells. In contrast to surface expression, we now report that much higher levels of both precursor and mature forms of LFA-1 molecules were found relative to MHC class I, another membrane glycoprotein, with metabolic labeling of IL-2-stimulated LAK cells compared with native NK cells. An 85-90 kDa glycoprotein, found in much higher quantities in LAK compared with NK cells, appeared to be a precursor of the 95 kDa beta chain of the beta 2 integrin family in human LAK cells because: (i) pulse-chase experiments using LAK cells demonstrated decreased 35S-labeling of the 85-90 kDa molecule with a concomitant increase in the radioactivity of the mature 95 kDa LFA-1 beta chain, (ii) results of protease treatment revealed that the two molecules share virtually identical peptide maps, and (iii) endoglycosaminidase F treatment of LAK cell lysates immunoprecipitated with antibody against LFA-1 beta resulted in the disappearance of both the 85-90 and 96 kDa LFA-1 beta signals, and appearance of a signal at approximately 76 kDa. Digestion of the same immunoprecipitates with neuraminidase resulted in the disappearance of the 95 kDa signal and revealed a single molecular weight signal corresponding to 85-90 kDa. These data suggest that a core protein of approximately 76 kDa becomes N-glycosylated, perhaps terminally with sialic acid residues, to mature into the 95 kDa form. Moreover, the rate of maturation of LFA-1 was more rapid in LAK than NK cells, with half times of 0.8 versus 1.5 h for the alpha chain and 3.7 versus 4.9 h for the beta chain for LAK versus NK cells respectively. IL-2 treatment of NK cells therefore alters the processing of LFA-1 molecules during the transition to LAK cells, providing a larger intracellular reservoir with which to replenish the surface molecule. Together with our previous observation that LFA-1 is phosphorylated and transduces signal more effectively in LAK than NK cells, the findings support the notion that adhesion molecules contribute to the increased function of LAK cells.
我们先前报道过,淋巴细胞功能相关抗原-1(LFA-1)是人类自然杀伤(NK)细胞和淋巴因子激活的杀伤(LAK)细胞上主要的白细胞整合素,其在NK细胞和LAK细胞表面的表达并无差异。与表面表达情况不同,我们现在报道,与另一种膜糖蛋白MHC I类分子相比,在用白细胞介素-2刺激的LAK细胞与天然NK细胞进行代谢标记时,发现LFA-1分子的前体和成熟形式的水平都要高得多。一种85 - 90 kDa的糖蛋白,在LAK细胞中比NK细胞中的含量高得多,它似乎是人类LAK细胞中β2整合素家族95 kDaβ链的前体,原因如下:(i)对LAK细胞进行脉冲追踪实验表明,85 - 90 kDa分子的35S标记减少,同时成熟的95 kDa LFA-1β链的放射性增加;(ii)蛋白酶处理结果显示,这两种分子的肽图几乎相同;(iii)用抗LFA-1β抗体免疫沉淀LAK细胞裂解物后,用内切糖苷酶F处理,导致85 - 90 kDa和96 kDa的LFA-1β信号消失,出现约76 kDa的信号。用神经氨酸酶消化相同的免疫沉淀产物导致95 kDa信号消失,并显示出对应于85 - 90 kDa的单一分子量信号。这些数据表明,大约76 kDa的核心蛋白发生了N-糖基化,可能最终带有唾液酸残基,从而成熟为95 kDa的形式。此外,LAK细胞中LFA-1的成熟速度比NK细胞更快,LAK细胞与NK细胞相比,α链的半衰期分别为0.8小时和1.5小时,β链的半衰期分别为3.7小时和4.9小时。因此,用白细胞介素-2处理NK细胞会在向LAK细胞转变的过程中改变LFA-1分子的加工过程,从而提供一个更大的细胞内储备库来补充表面分子。连同我们之前观察到的LFA-1在LAK细胞中比NK细胞中更易磷酸化且能更有效地转导信号这一现象,这些发现支持了粘附分子有助于增强LAK细胞功能这一观点。